Novo Nordisk’s semaglutide product to lose patent protection in China next year, according to L.E.K. Consulting.

That overweight person you’re judging might not be able to control the amount they eat. For ten years, Joshua Bell was part ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

For Poolbeg Pharma, the question is not simply whether it can fund its ambitions, but whether its pipeline can justify them.

Watsons Philippines gathered the brilliant names in the health, wellness, and beauty industry for its most anticipated annual ...

Regeneron Pharmaceuticals, Inc. (REGN) on Monday said that it has entered into a strategic in-licensing agreement with ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

Legal battle over semaglutide between Novo Nordisk and Indian drugmakers will set precedent for future opportunities and ...

Can artificial intelligence help companies cut food waste and advance one of the most easily achievable climate solutions?

While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...

As the U.S. retreats from the World Health Organization, China is partly filling the void. China looks to supplant the U.S.